Cytek Biosciences
CTKB
CTKB
102 hedge funds and large institutions have $630M invested in Cytek Biosciences in 2023 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 41 increasing their positions, 34 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
1% less funds holding
Funds holding: 103 → 102 (-1)
4% less capital invested
Capital invested by funds: $654M → $630M (-$24.5M)
6% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 17
Holders
102
Holding in Top 10
2
Calls
$928K
Puts
$1K
Top Buyers
| 1 | +$32.1M | |
| 2 | +$11.4M | |
| 3 | +$7.51M | |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$6.16M |
| 5 |
New York State Common Retirement Fund
Albany,
New York
|
+$5.07M |
Top Sellers
| 1 | -$9.02M | |
| 2 | -$8.3M | |
| 3 | -$4.3M | |
| 4 |
HIM
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
-$3.52M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$3.4M |